Brayan Alves, Dunja Simicic, Jessie Mosso, Thanh Phong Lê, Guillaume Briand, Wolfgang Bogner, Bernard Lanz, Bernhard Strasser, Antoine Klauser, Cristina Cudalbu
{"title":"14.1 T 下 1H-FID-MRSI 的降噪技术:蒙特卡罗验证和体内应用。","authors":"Brayan Alves, Dunja Simicic, Jessie Mosso, Thanh Phong Lê, Guillaume Briand, Wolfgang Bogner, Bernard Lanz, Bernhard Strasser, Antoine Klauser, Cristina Cudalbu","doi":"10.1002/nbm.5211","DOIUrl":null,"url":null,"abstract":"<p><p>Proton magnetic resonance spectroscopic imaging (<sup>1</sup>H-MRSI) is a powerful tool that enables the multidimensional non-invasive mapping of the neurochemical profile at high resolution over the entire brain. The constant demand for higher spatial resolution in <sup>1</sup>H-MRSI has led to increased interest in post-processing-based denoising methods aimed at reducing noise variance. The aim of the present study was to implement two noise-reduction techniques, Marchenko-Pastur principal component analysis (MP-PCA) based denoising and low-rank total generalized variation (LR-TGV) reconstruction, and to test their potential with and impact on preclinical 14.1 T fast in vivo <sup>1</sup>H-FID-MRSI datasets. Since there is no known ground truth for in vivo metabolite maps, additional evaluations of the performance of both noise-reduction strategies were conducted using Monte Carlo simulations. Results showed that both denoising techniques increased the apparent signal-to-noise ratio (SNR) while preserving noise properties in each spectrum for both in vivo and Monte Carlo datasets. Relative metabolite concentrations were not significantly altered by either method and brain regional differences were preserved in both synthetic and in vivo datasets. Increased precision of metabolite estimates was observed for the two methods, with inconsistencies noted for lower-concentration metabolites. Our study provided a framework for how to evaluate the performance of MP-PCA and LR-TGV methods for preclinical <sup>1</sup>H-FID MRSI data at 14.1 T. While gains in apparent SNR and precision were observed, concentration estimations ought to be treated with care, especially for low-concentration metabolites.</p>","PeriodicalId":19309,"journal":{"name":"NMR in Biomedicine","volume":" ","pages":"e5211"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Noise-reduction techniques for <sup>1</sup>H-FID-MRSI at 14.1 T: Monte Carlo validation and in vivo application.\",\"authors\":\"Brayan Alves, Dunja Simicic, Jessie Mosso, Thanh Phong Lê, Guillaume Briand, Wolfgang Bogner, Bernard Lanz, Bernhard Strasser, Antoine Klauser, Cristina Cudalbu\",\"doi\":\"10.1002/nbm.5211\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Proton magnetic resonance spectroscopic imaging (<sup>1</sup>H-MRSI) is a powerful tool that enables the multidimensional non-invasive mapping of the neurochemical profile at high resolution over the entire brain. The constant demand for higher spatial resolution in <sup>1</sup>H-MRSI has led to increased interest in post-processing-based denoising methods aimed at reducing noise variance. The aim of the present study was to implement two noise-reduction techniques, Marchenko-Pastur principal component analysis (MP-PCA) based denoising and low-rank total generalized variation (LR-TGV) reconstruction, and to test their potential with and impact on preclinical 14.1 T fast in vivo <sup>1</sup>H-FID-MRSI datasets. Since there is no known ground truth for in vivo metabolite maps, additional evaluations of the performance of both noise-reduction strategies were conducted using Monte Carlo simulations. Results showed that both denoising techniques increased the apparent signal-to-noise ratio (SNR) while preserving noise properties in each spectrum for both in vivo and Monte Carlo datasets. Relative metabolite concentrations were not significantly altered by either method and brain regional differences were preserved in both synthetic and in vivo datasets. Increased precision of metabolite estimates was observed for the two methods, with inconsistencies noted for lower-concentration metabolites. Our study provided a framework for how to evaluate the performance of MP-PCA and LR-TGV methods for preclinical <sup>1</sup>H-FID MRSI data at 14.1 T. While gains in apparent SNR and precision were observed, concentration estimations ought to be treated with care, especially for low-concentration metabolites.</p>\",\"PeriodicalId\":19309,\"journal\":{\"name\":\"NMR in Biomedicine\",\"volume\":\" \",\"pages\":\"e5211\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NMR in Biomedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/nbm.5211\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"BIOPHYSICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NMR in Biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/nbm.5211","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
摘要
质子磁共振光谱成像(1H-MRSI)是一种功能强大的工具,能以高分辨率对整个大脑的神经化学特征进行多维无创绘图。对 1H-MRSI 更高的空间分辨率的不断需求,导致人们对旨在减少噪声方差的基于后处理的去噪方法越来越感兴趣。本研究的目的是采用两种降噪技术,即基于马琴科-帕斯特尔主成分分析(MP-PCA)的去噪和低秩总广义变异(LR-TGV)重建,并测试它们对临床前 14.1 T 快速体内 1H-FID-MRSI 数据集的潜力和影响。由于体内代谢物图谱没有已知的基本真实值,因此使用蒙特卡罗模拟对两种降噪策略的性能进行了额外的评估。结果表明,这两种去噪技术都提高了表观信噪比(SNR),同时保留了体内和蒙特卡罗数据集每个频谱的噪声特性。两种方法都没有明显改变代谢物的相对浓度,而且合成数据集和体内数据集都保留了大脑区域差异。两种方法都能提高代谢物估算的精确度,但低浓度代谢物的估算结果不一致。我们的研究为如何评估 14.1 T 临床前 1H-FID MRSI 数据的 MP-PCA 和 LR-TGV 方法的性能提供了一个框架。虽然观察到了表观信噪比和精确度的提高,但仍需谨慎对待浓度估计,尤其是低浓度代谢物。
Noise-reduction techniques for 1H-FID-MRSI at 14.1 T: Monte Carlo validation and in vivo application.
Proton magnetic resonance spectroscopic imaging (1H-MRSI) is a powerful tool that enables the multidimensional non-invasive mapping of the neurochemical profile at high resolution over the entire brain. The constant demand for higher spatial resolution in 1H-MRSI has led to increased interest in post-processing-based denoising methods aimed at reducing noise variance. The aim of the present study was to implement two noise-reduction techniques, Marchenko-Pastur principal component analysis (MP-PCA) based denoising and low-rank total generalized variation (LR-TGV) reconstruction, and to test their potential with and impact on preclinical 14.1 T fast in vivo 1H-FID-MRSI datasets. Since there is no known ground truth for in vivo metabolite maps, additional evaluations of the performance of both noise-reduction strategies were conducted using Monte Carlo simulations. Results showed that both denoising techniques increased the apparent signal-to-noise ratio (SNR) while preserving noise properties in each spectrum for both in vivo and Monte Carlo datasets. Relative metabolite concentrations were not significantly altered by either method and brain regional differences were preserved in both synthetic and in vivo datasets. Increased precision of metabolite estimates was observed for the two methods, with inconsistencies noted for lower-concentration metabolites. Our study provided a framework for how to evaluate the performance of MP-PCA and LR-TGV methods for preclinical 1H-FID MRSI data at 14.1 T. While gains in apparent SNR and precision were observed, concentration estimations ought to be treated with care, especially for low-concentration metabolites.
期刊介绍:
NMR in Biomedicine is a journal devoted to the publication of original full-length papers, rapid communications and review articles describing the development of magnetic resonance spectroscopy or imaging methods or their use to investigate physiological, biochemical, biophysical or medical problems. Topics for submitted papers should be in one of the following general categories: (a) development of methods and instrumentation for MR of biological systems; (b) studies of normal or diseased organs, tissues or cells; (c) diagnosis or treatment of disease. Reports may cover work on patients or healthy human subjects, in vivo animal experiments, studies of isolated organs or cultured cells, analysis of tissue extracts, NMR theory, experimental techniques, or instrumentation.